Nichols William Garrett's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Jul 2, 2025
- Accession no.
- 0000950170-25-093035
- Filed
- Jul 2, 2025
- Trade date
- Jun 30, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.94K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols William GarrettCIK 0001618364 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | Common Stock | MOption exerciseAcquired | +781 | $1.29 | +$1,007.49 | 53,274 | Direct | |
| Jun 30, 2025 | Common Stock | SSaleDisposed | −781 | $5.04 | −$3,936.24 | 52,493 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | Common Stock | MOption exerciseDisposed | −781 | $0.00 | $0 | 30,314 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.